Need for Balancing Youth Protection and Adult Access: The Imperative of FDA’s Zyn Authorization
Wednesday, February 19, 2025
Posted by: Natalia Gromov
The U.S. Food and Drug Administration’s authorization of 20 Zyn nicotine pouch products addresses an ongoing need to provide adults who smoke with access to less harmful alternatives to combustible cigarettes. However, this decision also underscores the importance of ensuring that public health progress – marked by recent significant declines in youth tobacco and nicotine use – is not reversed. Helping adults who smoke and protecting youth are not competing priorities – they are shared responsibilities essential to advancing public health.
Learn more.
|
|
Email to a Friend